Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Curr Top Med Chem ; 24(12): 1035-1049, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38445699

RESUMO

During the last five decades, there has been tremendous development in our understanding of cancer biology and the development of new and novel therapeutics to target cancer. However, despite these advances, cancer remains the second leading cause of death across the globe. Most cancer deaths are attributed to the development of resistance to current therapies. There is an urgent and unmet need to address cancer therapy resistance. Tetrandrine, a bis-benzyl iso-quinoline, has shown a promising role as an anti-cancer agent. Recent work from our laboratory and others suggests that tetrandrine and its derivatives could be an excellent adjuvant to the current arsenal of anti-cancer drugs. Herein, we provide an overview of resistance mechanisms to current therapeutics and review the existing literature on the anti-cancer effects of tetrandrine and its potential use for overcoming therapy resistance in cancer.


Assuntos
Benzilisoquinolinas , Resistencia a Medicamentos Antineoplásicos , Neoplasias , Humanos , Benzilisoquinolinas/farmacologia , Benzilisoquinolinas/química , Benzilisoquinolinas/uso terapêutico , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Antineoplásicos/farmacologia , Antineoplásicos/química , Antineoplásicos/uso terapêutico
2.
J Mater Sci Mater Med ; 24(9): 2157-69, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23756965

RESUMO

New approaches based on topical treatments are needed for treating pain and impaired dermal blood flow. We used a topical Pluronic F127 hydrogel containing S-nitrosoglutathione (GSNO) as a prodrug to generate free NO, an effector molecule that exerts both dermal vasodilation and antinociceptive effects. GSNO-containing hydrogels underwent gelation above 12 °C and released free NO at rates that were directly dependent on the GSNO concentration in the range of 50-150 mM. The topical application of this material led to dose-response dermal vasodilation in healthy volunteers and to a reduction of up to 50 % of the hypernociception intensity in Wistar rats that were subjected to inflammatory pain. Mechanistic investigations indicated that the antinociceptive effect of the topical F127/GSNO hydrogels is produced by the local activation of the cGMP/PKG/KATP channel-signaling pathway, which was stimulated by the free NO that diffused through the skin. These results expand the scope of the biomedical applications of this material and may represent a new approach for the topical treatment of inflammatory pain.


Assuntos
Analgésicos/farmacologia , Hidrogéis , Óxido Nítrico/farmacologia , Pele/irrigação sanguínea , Vasodilatação/efeitos dos fármacos , Vasodilatadores/farmacologia , Administração Tópica , Adulto , Animais , Varredura Diferencial de Calorimetria , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Óxido Nítrico/administração & dosagem , Ratos , Ratos Wistar , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA